AR005374A1 - Albumina humana terapeutica con baja capacidad para la fijacion de aluminio - Google Patents

Albumina humana terapeutica con baja capacidad para la fijacion de aluminio

Info

Publication number
AR005374A1
AR005374A1 ARP970100050A ARP970100050A AR005374A1 AR 005374 A1 AR005374 A1 AR 005374A1 AR P970100050 A ARP970100050 A AR P970100050A AR P970100050 A ARP970100050 A AR P970100050A AR 005374 A1 AR005374 A1 AR 005374A1
Authority
AR
Argentina
Prior art keywords
albumina
low capacity
therapeutic human
therapeutic
albumin
Prior art date
Application number
ARP970100050A
Other languages
English (en)
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8293596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR005374(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of AR005374A1 publication Critical patent/AR005374A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se da a conocer una albúmina humana terapéutica con muy baja capacidad de absorción de aluminio, durante el tiempo de almacenamiento en envase de vidrio,en la que la composición final de la solución de albúmina ajustada de estabilizantese isotonía a la concentración del 5,20 o 25% de proteína enmedio acuoso, preferentemente, o a cualquier otra concentración terapéutica aceptable por vía intravenosa, presenta un contenido de citrato en lacomposición finas de albúmina igual oinf erior a 0,5 mM (milimolar) y, preferentemente, inferior a 0,037 mM (milimolar).
ARP970100050A 1996-01-30 1997-01-07 Albumina humana terapeutica con baja capacidad para la fijacion de aluminio AR005374A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09600200A ES2103236B1 (es) 1996-01-30 1996-01-30 Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.

Publications (1)

Publication Number Publication Date
AR005374A1 true AR005374A1 (es) 1999-04-28

Family

ID=8293596

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100050A AR005374A1 (es) 1996-01-30 1997-01-07 Albumina humana terapeutica con baja capacidad para la fijacion de aluminio

Country Status (13)

Country Link
US (1) US5846930A (es)
EP (2) EP0787498B1 (es)
JP (1) JP3054371B2 (es)
AR (1) AR005374A1 (es)
AT (1) ATE269717T1 (es)
CZ (1) CZ289782B6 (es)
DE (2) DE69632771T2 (es)
DK (1) DK0787498T3 (es)
ES (3) ES2103236B1 (es)
HU (1) HUP9603601A3 (es)
PT (1) PT787498E (es)
SK (1) SK284297B6 (es)
UY (1) UY24448A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
DE69929022T2 (de) 1998-10-21 2006-07-13 Nipro Corp. Verfahren zur Herstellung eines Kunststoffbehälters für eine Albuminzubereitung
US6693173B2 (en) * 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins
GB0117879D0 (en) 2001-07-21 2001-09-12 Common Services Agency Storage of liquid compositions
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
US6718735B2 (en) * 2002-03-19 2004-04-13 Baxter International Inc. Albumin in a flexible polymeric container
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
ES2294976B1 (es) 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
EP0452753B1 (en) * 1990-04-19 2004-06-23 Bayer Corporation Method for preparing essentially monomeric normal serum albumin (human)
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels

Also Published As

Publication number Publication date
PT787498E (pt) 2004-10-29
ATE269717T1 (de) 2004-07-15
CZ289782B6 (cs) 2002-04-17
SK284297B6 (sk) 2005-01-03
EP0787498A2 (en) 1997-08-06
HUP9603601A2 (en) 1997-08-28
JPH09221431A (ja) 1997-08-26
US5846930A (en) 1998-12-08
SK3597A3 (en) 1997-08-06
EP1413312A3 (en) 2004-09-01
EP0787498A3 (en) 1998-10-21
EP0787498B1 (en) 2004-06-23
HUP9603601A3 (en) 1998-01-28
ES2103236B1 (es) 1998-04-16
HU9603601D0 (en) 1997-02-28
CZ697A3 (en) 1997-08-13
EP1413312A2 (en) 2004-04-28
DK0787498T3 (da) 2004-10-11
ES2103236A1 (es) 1997-09-01
DE69632771T2 (de) 2005-07-07
JP3054371B2 (ja) 2000-06-19
UY24448A1 (es) 1997-02-18
ES2220967T3 (es) 2004-12-16
DE69632771D1 (de) 2004-07-29
MX9700617A (es) 1997-07-31
DE787498T1 (de) 1999-05-20
ES2220256T1 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
AR005374A1 (es) Albumina humana terapeutica con baja capacidad para la fijacion de aluminio
HUP0001936A2 (hu) Eljárás vértermékek tárolására, valamint az erre alkalmas oldatot tartalmazó tartóedény
ES2094923T3 (es) Procedimiento de preparacion de medicamentos conservados que contienen proteinas humanas, para fines de infusion o inyeccion.
JPS6490123A (en) Nitroglycerol spray agent
DK0819010T3 (da) Proteinformuleringer omfattende koagulationsfaktor VIII eller IX i en vandig sucroseopløsning
KR930001914A (ko) 안정화된 pvp-i 용액
WO1995027495A3 (en) Treatment of partial growth hormone insensitivity syndrome
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
ES2177579T3 (es) Solucion acuosa de factor viii de bajo contenido en oxigeno.
IL135186A0 (en) LIQUID INTERFERON-β FORMULATIONS
ES2097120T3 (es) Estabilizacion de proteinas altamente purificadas.
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
Hsu Lithium-resistant adolescent mania.
ATE421319T1 (de) Mit s-nitrosothiol angereicherte erythrocyten und deren verwendung
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
PT914148E (pt) Tratamento do sindroma de insensibilidade parcial a hormona de crescimento
RU95115956A (ru) Диализирующий дезинтоксикационный раствор для проведения диализа с сорбционным эффектом в гнойной хирургии
ATE167362T1 (de) Erfrischungsgetränk
Sadek et al. Thoracic duct changes in schistosomal hepatic fibrosis
Adamchik et al. The antithrombogenic properties of the vascular wall and platelet aggregation in patients with atherosclerosis of the arteries of the lower extremities following a course of treatment with UV-irradiated autologous blood transfusion
Repine A Potential Role for Oxygen Radicals in Mineral Dust-Induced Lung Injury: Lessons from Lung Injury from Hyperoxia
NZ504194A (en) Physiologically acceptable aqueous solutions and methods for their use
MD742C2 (ro) Remediu cu activitate regenerativă
CIUsA et al. Membrane Alterations in G6PD-and PK-Deficient Erythrocytes Exposed to Oxidizing Agents

Legal Events

Date Code Title Description
FC Refusal